NASDAQ:CAPR
Capricor Therapeutics Stock News
$5.24
-0.0900 (-1.69%)
At Close: May 02, 2024
Capricor Therapeutics and Nippon Shinyaku Enter Partnership for Exclusive Commercialization and Distribution of CAP-1002 for the Treatment of Duchenne Muscular Dystrophy in the U.S.
10:00am, Tuesday, 25'th Jan 2022 GlobeNewswire Inc.
-Partnership Leverages Nippon Shinyaku’s Deep Experience in Drug Development for Rare Diseases and its Commercial DMD Franchise in the U.S.-
Forget Bargains, Play 5 Stocks With Rising P/E Instead
12:57pm, Thursday, 30'th Dec 2021 Zacks Investment Research
Forget undervalued stocks, there is room for upside even in stocks with rising P/E.
Forget Bargains, Play 5 Stocks With Rising P/E Instead
09:12am, Thursday, 30'th Dec 2021
Forget undervalued stocks, there is room for upside even in stocks with rising P/E.
Analyzing Rallybio (NASDAQ:RLYB) and Capricor Therapeutics (NASDAQ:CAPR)
10:18am, Tuesday, 14'th Dec 2021 Dakota Financial News
Rallybio (NASDAQ:RLYB) and Capricor Therapeutics (NASDAQ:CAPR) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, valuation, earnings and profitability. Analyst Ratings This is a breakdown of recent ratings and recommmendations for Rallybio and Capricor Therapeutics, […]
Capricor Therapeutics provides key updates on its COVID-19 vaccine programs
02:43pm, Monday, 13'th Dec 2021 Seeking Alpha
Capricor Therapeutics Announces Key Updates on its Vaccine and Therapeutic Programs for COVID-19
02:15pm, Monday, 13'th Dec 2021 GlobeNewswire Inc.
Capricor’s Exosome-based mRNA Vaccine for SARS-CoV-2-In-Vivo Preclinical Data Published in the Journal of Biological Chemistry--Preclinical Data Demonstrates Strong T-Cell Response for High Conserve
Muscular Dystrophy Treatment Market Future Business Opportunities 2021-2028 | Acceleron Pharma, Capricor Therapeutics, Bristol-Myers Squibb, Lexicon Pharmaceuticals
05:30am, Saturday, 11'th Dec 2021 OpenPR
Global Muscular Dystrophy Treatment Market has potentials to grow as the most influential market worldwide as it has been playing a noteworthy role in imprinting positive impacts on the international economy. The Global Muscular Dystrophy Treatment Market Report offers vital
Here's Why Capricor (CAPR) is Poised for a Turnaround After Losing 19.3% in 4 Weeks
03:00pm, Friday, 19'th Nov 2021 Zacks Investment Research
Capricor (CAPR) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising
Here's Why Capricor (CAPR) is Poised for a Turnaround After Losing 19.3% in 4 Weeks
11:30am, Friday, 19'th Nov 2021
Capricor (CAPR) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising
Capricor Therapeutics, Inc. (CAPR) CEO Linda Marbán on Q3 2021 Results - Earnings Call Transcript
08:10pm, Tuesday, 09'th Nov 2021
Capricor Therapeutics, Inc. (CAPR) CEO Linda Marbán on Q3 2021 Results - Earnings Call Transcript
Capricor Stock Is Moving Higher As Duchenne Dystrophy Cell Therapy Slows Disease Progression By 71%
09:28am, Friday, 24'th Sep 2021
Capricor Therapeutics Inc (NASDAQ: CAPR) has announced final data from Phase 2 HOPE-2 trial of CAP-1002 for advanced stages of Duchenne muscular dystrophy (DMD). The trial met its primary efficac
CAPR Stock: Why It Substantially Increased Today
07:25am, Friday, 24'th Sep 2021
The stock price of Capricor Therapeutics Inc (NASDAQ: CAPR) increased by over 17% pre-market. This is why it happened.
–Trial Met its Primary Efficacy Endpoint of Mid-level Performance of Upper Limb (PUL) v1.2 (p=0.01)–
Capricor Therapeutics to Present at the Upcoming Investor and Industry Healthcare Conferences
04:05pm, Wednesday, 22'nd Sep 2021
- Cantor Fitzgerald Virtual Global Healthcare Conference: September 30 -
Best Penny Stocks To Buy? 5 To Watch This Week With Biotech Catalysts
10:25am, Sunday, 19'th Sep 2021
Penny stocks with important dates to know this week. The post Best Penny Stocks To Buy?
